Sabine Royalty Trust
Sabine Royalty Trust (SBR) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Sabine Royalty Trust (SBR), featuring income statements, balance sheets, and cash flow data.
Sabine Royalty Trust (SBR) Income Statement & Financial Overview
Review Sabine Royalty Trust SBR income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $19.42M | $19.78M | $22.78M | $20.91M |
Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Gross Profit | $19.42M | $19.78M | $22.78M | $20.91M |
Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $975754.00 | $859880.00 | $703464.00 | $989304.00 |
Operating Expenses | $975754.00 | $19.78M | $703464.00 | $984245.00 |
Total Costs & Expenses | $975754.00 | $19.78M | $703464.00 | $989304.00 |
Interest Income | $128308.00 | $145868.00 | $175353.00 | $151926.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | -$128308.00 | -$5145.00 | $5276.00 | $5059.00 |
EBITDA | $18.44M | $18.92M | $21.90M | $19.93M |
EBITDA Ratio | $0.95 | $0.96 | $0.96 | $0.95 |
Operating Income | $18.44M | $18.92M | $22.08M | $19.92M |
Operating Income Ratio | $0.95 | $0.96 | $0.97 | $0.95 |
Other Income/Expenses (Net) | $128308.00 | $145868.00 | $0.00 | $0.00 |
Income Before Tax | $18.57M | $19.07M | $22.08M | $19.92M |
Income Before Tax Ratio | $0.96 | $0.96 | $0.97 | $0.95 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $1.00 |
Net Income | $18.57M | $19.07M | $22.08M | $19.92M |
Net Income Ratio | $0.96 | $0.96 | $0.97 | $0.95 |
EPS | $1.27 | $1.31 | $1.51 | $1.37 |
Diluted EPS | $1.27 | $1.31 | $1.51 | $1.37 |
Weighted Avg Shares Outstanding | $14.58M | $14.58M | $14.58M | $14.58M |
Weighted Avg Shares Outstanding (Diluted) | $14.58M | $14.58M | $14.58M | $14.58M |
Over the past four quarters, Sabine Royalty Trust demonstrated steady revenue growth, increasing from $20.91M in Q1 2024 to $19.42M in Q4 2024. Operating income reached $18.44M in Q4 2024, maintaining a consistent 95% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $18.44M, reflecting operational efficiency. Net income dropped to $18.57M, with EPS at $1.27. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan